Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2

被引:11
作者
Kosillo, Polina [1 ]
Ahmed, Kamran M. [1 ]
Aisenberg, Erin E. [2 ]
Karalis, Vasiliki [1 ]
Roberts, Bradley M. [3 ]
Cragg, Stephanie J. [3 ]
Bateup, Helen S. [1 ,2 ,4 ]
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA
[3] Univ Oxford, Dept Physiol Physiol Anat & Genet, Oxford, England
[4] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA
来源
ELIFE | 2022年 / 11卷
基金
美国国家卫生研究院;
关键词
mTORC1; mTORC2; raptor; rictor; dopamine neurons; TSC; Mouse; COMPLEX; 1; TUBEROUS SCLEROSIS; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; MAMMALIAN TARGET; BASAL GANGLIA; BRAIN; AKT; RELEASE; RICTOR;
D O I
10.7554/eLife.75398
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The mTOR pathway is an essential regulator of cell growth and metabolism. Midbrain dopamine neurons are particularly sensitive to mTOR signaling status as activation or inhibition of mTOR alters their morphology and physiology. mTOR exists in two distinct multiprotein complexes termed mTORC1 and mTORC2. How each of these complexes affect dopamine neuron properties, and whether they have similar or distinct functions is unknown. Here, we investigated this in mice with dopamine neuron-specific deletion of Rptor or Rictor, which encode obligatory components of mTORC1 or mTORC2, respectively. We find that inhibition of mTORC1 strongly and broadly impacts dopamine neuron structure and function causing somatodendritic and axonal hypotrophy, increased intrinsic excitability, decreased dopamine production, and impaired dopamine release. In contrast, inhibition of mTORC2 has more subtle effects, with selective alterations to the output of ventral tegmental area dopamine neurons. Disruption of both mTOR complexes leads to pronounced deficits in dopamine release demonstrating the importance of balanced mTORC1 and mTORC2 signaling for dopaminergic function.
引用
收藏
页数:43
相关论文
共 50 条
  • [31] mTORC1 and mTORC2 Differentially Regulate Cell Fate Programs to Coordinate Osteoblastic Differentiation in Mesenchymal Stromal Cells
    Schaub, Theres
    Guergen, Dennis
    Maus, Deborah
    Lange, Claudia
    Tarabykin, Victor
    Dragun, Duska
    Hegner, Bjoern
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [32] Dual inhibition of mTORC1 and mTORC2 perturbs cytoskeletal organization and impairs endothelial cell elongation
    Tsuji-Tamura, Kiyomi
    Ogawa, Minetaro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 326 - 331
  • [33] Preclinical Characterization of OSI-027, a Potent and Selective Inhibitor of mTORC1 and mTORC2: Distinct from Rapamycin
    Bhagwat, Shripad V.
    Gokhale, Prafulla C.
    Crew, Andrew P.
    Cooke, Andy
    Yao, Yan
    Mantis, Christine
    Kahler, Jennifer
    Workman, Jennifer
    Bittner, Mark
    Dudkin, Lorina
    Epstein, David M.
    Gibson, Neil W.
    Wild, Robert
    Arnold, Lee D.
    Houghton, Peter J.
    Pachter, Jonathan A.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1394 - 1406
  • [34] mTORC2 and AMPK differentially regulate muscle triglyceride content via Perilipin 3
    Kleinert, Maximilian
    Parker, Benjamin L.
    Chaudhuri, Rima
    Fazakerley, Daniel J.
    Serup, Annette
    Thomas, Kristen C.
    Krycer, James R.
    Sylow, Lykke
    Fritzen, Andreas M.
    Hoffman, Nolan J.
    Jeppesen, Jacob
    Schjerling, Peter
    Ruegg, Markus A.
    Kiens, Bente
    James, David E.
    Richter, Erik A.
    MOLECULAR METABOLISM, 2016, 5 (08): : 646 - 655
  • [35] Hypoxia-induced endothelial proliferation requires both mTORC1 and mTORC2
    Li, Weimin
    Petrimpol, Marco
    Molle, Klaus D.
    Hall, Michael N.
    Battegay, Edouard J.
    Humar, Rok
    CIRCULATION RESEARCH, 2007, 100 (01) : 79 - 87
  • [36] Regulation of mTORC1 and mTORC2 Complex Assembly by Phosphatidic Acid: Competition with Rapamycin
    Toschi, Alfredo
    Lee, Evan
    Xu, Limei
    Garcia, Avalon
    Gadir, Noga
    Foster, David A.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (06) : 1411 - 1420
  • [37] The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2
    Delgoffe, Greg M.
    Pollizzi, Kristen N.
    Waickman, Adam T.
    Heikamp, Emily
    Meyers, David J.
    Horton, Maureen R.
    Xiao, Bo
    Worley, Paul F.
    Powell, Jonathan D.
    NATURE IMMUNOLOGY, 2011, 12 (04) : 295 - U117
  • [38] Rac1 Regulates the Activity of mTORC1 and mTORC2 and Controls Cellular Size
    Saci, Abdelhafid
    Cantley, Lewis C.
    Carpenter, Christopher L.
    MOLECULAR CELL, 2011, 42 (01) : 50 - 61
  • [39] IKK interacts with rictor and regulates mTORC2
    Xu, Yuanfei
    Lai, Eryong
    Liu, Jun
    Lin, Jun
    Yang, Cuilan
    Jia, Chunhong
    Li, Yunfeng
    Bai, Xiaochun
    Li, Ming
    CELLULAR SIGNALLING, 2013, 25 (11) : 2239 - 2245
  • [40] Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation
    Kazyken, Dubek
    Lentz, Stephen I.
    Wadley, Maxwell
    Fingar, Diane C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (09)